Table 1. Clinical and Procedural Characteristics.
Continuous normally-distributed variables are presented as mean ± standard deviation. Continuous not-normally-distributed variables are presented as median (interquartile range). Frequencies are expressed as number (percentage).
(BARI: Bypass Angioplasty Revascularization Investigation; DES: drug eluting stent; ECG: electrocardiographic; GPIIbIIIa: glycoprotein IIbIIIa; IHD: Ischemic Heart disease; IMR: index of microcirculatory resistance; LAD: left anterior descending; LCx: left circumflex; MBG: myocardial blush grade; MLD: minimal lumen diameter;RCA: right coronary artery; TIMI: thrombolysis in myocardial infarction; 2D QCA: two dimensional quantitative coronary angiography; %DS: percentage of diameter stenosis; ∑STR: ST resolution)
| Whole Cohort (25 pts) | |
|---|---|
| Male gender | 22 (88.8) |
| Age | 58.2 ± 10.0 |
| Hypertension | 10 (40.0) |
| Hypercholesterolemia | 9 (36.0) |
| Diabetes mellitus | 2 (8.0) |
| Active Smoker | 15 (60.0) |
| Family History of IHD | 11(44.0) |
| Previous Cardiological History | 9 (36.0) |
| Pain to wire time | |
| < 3 hours | 12 (48.0) |
| ≥ 3 hours and < 6 hours | 9 (36.0) |
| ≥ 6 hours | 4 (16.0) |
| Culprit vessel | |
| LAD | 10 (40.0) |
| LCx | 1 (4.0) |
| RCA | 14 (56.0) |
| TIMI flow at presentation | |
| 0 | 20 (80.0) |
| 1 | 2 (8.0) |
| 2 | 2 (8.0) |
| 3 | 1 (4.0) |
| Vessel closed at presentation | 21 (84.0) |
| Thrombus Score | |
| 0-1-2 | 4 (16.0) |
| 3 | 5 (20.0) |
| 4 | 16 (64.0) |
| 5 | 0 (0.0) |
| Rentrop Score | |
| 0 | 20 (80.0) |
| 1 | 3 (12.0) |
| 2 | 2 (8.0) |
| 3 | 0 (0.0) |
| Number vessel disease | |
| 1 | 19 (76.0) |
| 2 | 4 (16.0) |
| 3 | 2 (8.0) |
| Syntax Score | 7.0 (4.0- 9.5) |
| BARI Jeopardy Score | 29.3 ± 7.7 |
| Troponin peak (ng/ml) | 110.4 (36.6 – 209.6) |
| Troponin AUC | 185.3 (89.7 – 315.0) |
| Creatinin (µmol/ml) | 74.4 ± 13.7 |
| Periprocedural Medications | |
| Aspirin | 25 (100.0) |
| Clopidogrel | 25 (100.0) |
| Bivalirudin | 25 (100.0) |
| GPIIbIIIa inhibitors | |
| Total adopted | 5 (20.0) |
| Bail out | 5 (20.0) |
| Thrombus Aspiration | 23 (92.0) |
| Predilation | 25 (100.0) |
| Max balloon diameter (mm) | 2.5 ± 0.3 |
| Prestent 2D-QCA | |
| MLD (mm) | 1.31± 0.53 |
| %DS | 54.1 ± 15.2 |
| Lesion Length (mm) | 16.5 ± 8.5 |
| DES | 23 (92.0) |
| 2nd generation | 22 (88.0) |
| PES | 1 (4.0) |
| EES | 20 (80.0) |
| ZES | 2 (8.0) |
| Number of stents | |
| 1 | 23 (92.0) |
| 2 | 2 (8.0) |
| ≥ 3 | 0 (0.0) |
| Stent length (mm) | 24.0 (18.0 - 32.0) |
| Stent Diameter (mm) | 3.5 (3.0 – 4.0) |
| Postdilation | 20 (80.0) |
| Number of postdilations | 2.0 (1.0 – 3.0) |
| Max postdilation pressure (atm) | 16.3 ± 2.9 |
| Max balloon diameter (mm) | 3.8 ± 0.6 |
| Final TIMI flow | |
| 0 | 0 (0.0) |
| 1 | 0 (0.0) |
| 2 | 0 (0.0) |
| 3 | 25 (100.0) |
| MBG | |
| 0-1 | 2 (8.0) |
| 2 | 9 (36.0) |
| 3 | 14 (56.0) |
| Incomplete ∑STR (< 70%) | 4 (16.0) |
| Angiographic Distal Embolization | 1 (4.0) |
| MBG < 2 and/or Incomplete ∑STR (< 70%) | 6 (24.0) |